Home
Caplin Point Laboratories Limited
Press Release Mar 03 2023
Business
Mar 3 2023
5 min read

Press Release Mar 03 2023

Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated March 03, 2023, titled "Press Release regarding grant of USFDA approval for Rocuronium Bromide Injection to our Subsidiary Caplin Steriles Limited. ".

View Attachment

Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren